other material
confidence high
sentiment neutral
materiality 0.30
Ginkgo files Zymergen Q3 2022 financials; net loss $75.7M on $2.3M revenue
Ginkgo Bioworks Holdings, Inc.
- Zymergen Q3 2022: revenue $2.3M, net loss $75.7M, operating loss $75.3M.
- Nine-month 2022: revenue $9.7M, net loss $264.3M, operating loss $245.1M.
- Cash $153.4M at Sep 30, 2022, down from $386.1M at Dec 31, 2021.
- Goodwill impairment charge of $40.6M recorded during 2022.
- Going-concern doubt that existed at June 30, 2022 alleviated by Oct 19, 2022 merger.